X
    X
    X
    X

    Locke Lord Team’s Representation of Client Zydus in Patent Win Over Shire Highlighted in IP Law360

    Articles

    Michael Gaertner, Keith ParrJames PeterkaDavid AbramowitzAndy MillerWasim BleibelTimothy Peterson (all of Chicago) and Andrea Wayda (New York) successfully represented Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited by securing a ruling after a bench trial that Zydus’s proposed generic version of Shire Development LLC’s ulcerative colitis drug Lialda would not infringe Shire’s U.S. Patent No. 6,773,720.

    To read the complete article, click here (subscription may be required).

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.